N. Chakraborty

发表

Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.

L. Butterfield, S. Mehrotra, J. Economou, 2003, Cancer research.

Immune Metabolism in Functional Aspects of the Brain

N. Chakraborty, Elisa Gonzalez Cuevas, 2019, American Journal of Immunology.

Acknowledgement

D. Busch, H. Einsele, M. Dhodapkar, 1987, Hearing Research.

Immunobiology and immunotherapy of melanoma

N. Chakraborty, B. Mukherji, 1995, Current opinion in oncology.

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.

J. Ozols, H. Yamase, N. Chakraborty, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Knockdown of T‐bet expression in Mart‐127–35‐specific T‐cell‐receptor‐engineered human CD4+ CD25− and CD8+ T cells attenuates effector function

D. Dorsky, Prashant Singh, N. Chakraborty, 2015, Immunology.

Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death.

M. Nishimura, S. Mehrotra, A. Lesher, 2009, Cancer research.

MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.

A. Ribas, S. Rosenberg, U. Hegde, 2010, Clinical immunology.

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.

S. Mehrotra, S. Chattopadhyay, A. Chhabra, 2004, Human immunology.

Stimulatory and inhibitory differentiation of human myeloid dendritic cells.

L. Li, N. Chakraborty, B. Mukherji, 2000, Clinical immunology.

The Etiological Role of Microglia in Autism Spectrum Disorder: A Possible Route for Early Intervention

N. Chakraborty, R. Slovak, Ryan Slovak, 2017 .

Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly.

R. Feinn, U. Hegde, J. Grant-Kels, 2013, Human immunology.

Regulatory T cells and tumor immunity

S. Chattopadhyay, N. Chakraborty, B. Mukherji, 2005, Cancer Immunology, Immunotherapy.

CD4+CD25− T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model1

D. Baltimore, B. Comin-Anduix, A. Ribas, 2008, The Journal of Immunology.

Function in a Human Melanoma Model MHC Class I-Restricted Cytolytic Effector TCR Synthesize Th 1 Cytokines and Exhibit MHC Class I-Restricted Epitope-Specific T Cells Transduced to Express − CD 25 + CD 4 Baltimore and Bijay Mukherji

D. Baltimore, B. Comin-Anduix, A. Ribas, 2008 .

Comparative Analysis of Induced CD4+ Tregs (Itreg) In Response to CD8+ CTL Induction From PBL By MHC-I Bound Mart-1 Peptide Pulsed DC or Autologous Tumor Cells with Freshly Isolated TIL from Human Melanoma.

U. Hegde, N. Chakraborty, S. Jha, 2016 .

Effect of CD4+CD25+ and CD4+CD25− T Regulatory Cells on the Generation of Cytolytic T Cell Response to a Self but Human Tumor-Associated Epitope In Vitro1

S. Mehrotra, U. Hegde, S. Chattopadhyay, 2006, The Journal of Immunology.

Activation‐induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis‐inducing factor

S. Mehrotra, D. Dorsky, A. Chhabra, 2006, European journal of immunology.

Inhibition of c‐Jun N‐terminal kinase rescues influenza epitope‐specific human cytolytic T lymphocytes from activation‐induced cell death

S. Mehrotra, U. Hegde, A. Chhabra, 2007, Journal of leukocyte biology.

Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation

S. Mehrotra, P. Albertsen, R. Stevens, 2003, Cancer Immunology, Immunotherapy.

T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules.

S. Mehrotra, A. Al-Khami, N. Chakraborty, 2011, Cytokine.

Vitamin D: The Immunologic Role and its Effect on Human Pathophysiology

N. Chakraborty, W. Whalen, Edward Cook, 2015 .

Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.

L. Butterfield, L. Li, J. Economou, 1998, Cancer research.

Rescuing Melanoma Epitope-Specific Cytolytic T Lymphocytes from Activation-Induced Cell Death, by SP600125, an Inhibitor of JNK: Implications in Cancer Immunotherapy1

S. Mehrotra, S. Chattopadhyay, D. Dorsky, 2004, The Journal of Immunology.

Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus.

A. Ribas, L. Butterfield, W. McBride, 1998, Journal of immunology.

Adenovirus Lymphocytes by Dendritic Cells Transduced Generation of Melanoma-Specific Cytotoxic T

A. Ribas, L. Butterfield, W. McBride, 1998 .

Genetically predisposed, life style and occurrence of metastatic cancer

N. Chakraborty, 2007, Indian journal of human genetics.

U. Chattopadhyay, N. Chakraborty, A. Chakraborty, 1994, Tumori.

Emergence of regulatory CD4+ T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines.

L. Li, S. Kurtzman, N. Chakraborty, 1999, Journal of immunology.

Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma

S. Kurtzman, H. Yamase, N. Chakraborty, 1998, Cancer Immunology, Immunotherapy.

Clonal expansion of T cells following in vitro stimulation with autologous melanoma cells and interleukin-2 studied by molecular analysis of a T cell receptor.

G. Robbins, N. Chakraborty, B. Mukherji, 1991, Immunology letters.

Cell-Based Tumor Vaccines Implications in Designing Antigen-Presenting Antigen-Presenting Cells In Vitro: Response to Repetitive Stimulation with T Cell + Emergence of Regulatory CD4

S. Kurtzman, N. Chakraborty, B. Mukherji, 1999 .

Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine.

S. Kurtzman, N. Chakraborty, B. Mukherji, 1996, Cancer research.

Continuous presence of Th1 conditions is necessary for longer lasting tumor-specific CTL activity in stimulation cultures with PBL.

S. Chattopadhyay, N. Chakraborty, 2005, Human immunology.

Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.

N. Chakraborty, B. Mukherji, J. Sporn, 1991, Clinical immunology and immunopathology.

Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy

N. Chakraborty, 2009, Indian journal of human genetics.

Advances in Brief Human Melanoma-specific , Noncytolytic CD 8 + T Cells That Can Synthesize Type I Cytokine 1

N. Chakraborty, B. Mukherji, 2006 .

Human melanoma-specific, noncytolytic CD8+ T cells that can synthesize type I cytokine.

N. Chakraborty, B. Mukherji, 1998, Cancer research.

Presentation of synthetic peptide antigen encoded by the MAGE-1 gene by granulocyte/macrophage-colony-stimulating-factor-cultured macrophages from HLA-A1 melanoma patients

A. Sampieri, W. Adkisson, N. Chakraborty, 1995, Cancer Immunology, Immunotherapy.

Presence of Low Dose of Fludarabine in Cultures Blocks Regulatory T Cell Expansion and Maintains Tumor-Specific Cytotoxic T Lymphocyte Activity Generated with Peripheral Blood Lymphocytes

U. Hegde, S. Chattopadhyay, A. Chhabra, 2008, Pathobiology.

Immunotherapy an Inhibitor of JNK : Implications in Cancer Activation-Induced Cell Death , by SP 600125 , Cytolytic T Lymphocytes from Rescuing Melanoma Epitope-Specific

S. Mehrotra, D. Dorsky, A. Chhabra, 2004 .

Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavity and during aging

U. Chattopadhyay, N. Chakraborty, A. Chakraborty, 1996, International journal of cancer.

Fighting our Own Battles: the Role of our Immune System in Health and Disease

N. Chakraborty, S. Karimi, 2016 .

Acriflavine-Induced Surface Changes in Three Tumor Cell Types and Differential Sensitivity to Lectins

N. Chakraborty, J. Chowdhury, Jayasree Roy Chowdhury, 1984, Tumori.

Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35.

A. Chhabra, N. Chakraborty, B. Mukherji, 2008, Clinical immunology.

Macrophages as Stimulators of MART-127–35 Epitope-Specific Human Cytolytic T Lymphocytes in vitro

S. Mehrotra, N. Chakraborty, B. Mukherji, 2007, Pathobiology.

Adoptive transfer of activated human autologous macrophages results in regression of transplanted human melanoma cells in SCID mice.

D. Twardzik, H. Yamase, P. Stabach, 1991, In vivo.

T‐Cell Clones that react against Autologous Human Tumors

N. Chakraborty, M. Sivanandham, Buay Mukherji, 1990, Immunological reviews.

The Oxazolidinone Derivative Locostatin Induces Cytokine Appeasement1

D. Allen, S. Ngoi, A. Vella, 2009, The Journal of Immunology.

GITR expression on T-cell receptor-stimulated human CD8+ T cell in a JNK-dependent pathway

S. Chattopadhyay, N. Chakraborty, 2009, Indian journal of human genetics.

Antigen presentation by MART‐1 adenovirus‐transduced interleukin‐10‐polarized human monocyte‐derived dendritic cells

L. Butterfield, S. Mehrotra, S. Chattopadhyay, 2004, Immunology.

Autologous melanoma-induced activation of regulatory T cells that suppress cytotoxic response.

D. Twardzik, K. Hellstrom, N. Chakraborty, 1990, Journal of immunology.

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

N. Chakraborty, B. Mukherji, J. Sporn, 1989, The Journal of experimental medicine.

Cross‐presentation of a human tumor antigen delivered to dendritic cells by HSV VP22‐mediated protein translocation

S. Mehrotra, D. Dorsky, A. Chhabra, 2004, European journal of immunology.

Transcriptional Profiles of Mart-1(27-35) Epitope Specific TCReng Human CD8+ and CD4+ T Cells upon Epitope Encounter as Elucidated by RNASeq

U. Hegde, D. Dorsky, U. Farooq, 2014 .

Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma.

A. Ribas, S. Mehrotra, J. Economou, 2009, Clinics in dermatology.

Manipulation of regulatory T cells and antigen‐specific cytotoxic T lymphocyte‐based tumour immunotherapy

S. Chattopadhyay, N. Chakraborty, S. Karimi, 2015, Immunology.

Metastatic melanoma in the older patient: immunologic insights and treatment outcomes

U. Hegde, N. Chakraborty, B. Mukherji, 2011, Expert review of pharmacoeconomics & outcomes research.

Melanoma in the elderly patient: relevance of the aging immune system.

U. Hegde, J. Grant-Kels, N. Chakraborty, 2009, Clinics in dermatology.

Stimulatory and Inhibitory Maturation of Human Macrophage-Derived Dendritic Cells

N. Chakraborty, B. Mukherji, A. Chakraborty, 2000, Pathobiology.

Platinum in blood mononuclear cells from patients after cisplatin therapy.

S. Hopfer, F. W. Sunderman, N. Chakraborty, 1990, Annals of clinical and laboratory science.

This information is current as Function in a Human Melanoma Model MHC Class I-Restricted Cytolytic Effector TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Epitope-Specific T Cells Transduced to Express - CD4+CD25

S. Mehrotra, J. Economou, D. Dorsky, 2013 .